Reliability of Interleukin-6 Alone and in Combination for Diagnosis of Early Onset Neonatal Sepsis: Systematic Review

Julia Eichberger, Bernhard Resch, Julia Eichberger, Bernhard Resch

Abstract

Neonatal sepsis is a major cause of morbidity and mortality in both preterm and term infants. Early-onset neonatal sepsis (EONS) presents within the first 72 h of life. Diagnosis is difficult as signs and symptoms are non-specific, and inflammatory markers are widely used to confirm or rule out neonatal sepsis. Interleukin-6 (IL-6) is part of the fetal inflammatory response syndrome (FIRS) and therefore an interesting early marker for neonatal sepsis. The main objective for this review was to assess the diagnostic potential of IL-6, alone and in combination, for diagnosis of early neonatal sepsis (EONS) in term and preterm infants, in cord and peripheral blood, and in dependence of timing of sample collection. IL-6 diagnostic accuracy studies for diagnosing EONS published between 1990 and 2020 were retrieved using the PubMed database. We included 31 out of 204 articles evaluating the potential of IL-6 for the diagnosis of EONS in a study population of newborns with culture-proven and/or clinically suspected sepsis. We excluded articles dealing with neonatal bacterial infections other than sepsis and biomarkers other than inflammatory markers, those written in languages other than English or German, studies that did not distinguish between EONS and late-onset sepsis, and animal and in vitro studies. Full-text articles were checked for other relevant studies according to the PRISMA criteria. We identified 31 studies on IL-6 diagnostic accuracy for EONS diagnosis between 1990 and 2020 including a total of 3,276 infants. Sensitivity and specificity were reported, and subgroup analysis was performed. A STARD checklist adapted for neonates with neonatal sepsis was used for quality assessment. The range of IL-6 sensitivity and specificity in neonatal samples was 42.1-100% and 43-100%; the median values were 83 and 83.3%, respectively. IL-6 accuracy was better in preterm infants than in mixed-study populations. Early sample collection at the time of sepsis suspicion had the highest sensitivity when compared to other time points. Cord blood IL-6 had higher diagnostic value compared to peripheral blood. The biomarker combination of IL-6 and CRP was found to be highly sensitive, but poorly specific. Limitations of this review include use of only one database and inclusion of a heterogeneous group of studies and a small number of studies looking at biomarker combinations; a strength of this review is its focus on early-onset sepsis, since type of sepsis was identified as a significant source of heterogeneity in IL-6 diagnostic accuracy studies. We concluded that IL-6 has a good performance as an early diagnostic marker of EONS within a study population of preterm infants, with best results for cord blood IL-6 using cutoff values above 30 pg/ml.

Keywords: diagnostic accuracy; early onset neonatal sepsis; interleukin-6 (IL-6); meta-analysis; sensitivity and specificity.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Eichberger and Resch.

Figures

FIGURE 1
FIGURE 1
Flowchart of the study selection process for diagnostic accuracy of interleukin-6 in early onset neonatal sepsis between 1990 and 2020.
FIGURE 2
FIGURE 2
Boxplots showing the distribution of IL-6 cutoff (A), sensitivity, and specificity values (B) of all diagnostic accuracy studies on EONS using neonatal samples.
FIGURE 3
FIGURE 3
Forest plots showing the individual and pooled sensitivities (A) and specificities (B) of IL-6 diagnostic accuracy studies for the diagnosis of EONS.

References

    1. Bakhuizen SE, de Haan TR, Teune MJ, van Wassenaer-Leemhuis AG, van der Heyden JL, van der Ham DP, et al. Meta-analysis shows that infants who have suffered neonatal sepsis face an increased risk of mortality and severe complications. Acta Paediatr. (2014) 103:1211–8. 10.1111/apa.12764
    1. Doellner H, Arntzen KJ, Haereid PE, Aag S, Austgulen R. Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr. (1998) 132:295–9. 10.1016/s0022-3476(98)70448-2
    1. Kashlan F, Smulian J, Shen-Schwarz S, Anwar M, Hiatt M, Hegyi T. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J. (2000) 19:238–43. 10.1097/00006454-200003000-00013
    1. Ebenebe CU, Hesse F, Blohm ME, Jung R, Kunzmann S, Singer D. Diagnostic accuracy of interleukin-6 for early-onset sepsis in preterm neonates. J Matern Fetal Neonatal Med. (2021) 34:253–8. 10.1080/14767058.2019.1606194
    1. Yang KD, He Y, Xiao S, Ai Q, Yu JL. Identification of progranulin as a novel diagnostic biomarker for early-onset sepsis in neonates. Eur J Clin Microbiol Infect Dis. (2020) 39:2405–14. 10.1007/s10096-020-03981-x
    1. Cobo T, Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, et al. Umbilical cord blood IL-6 as predictor of early-onset neonatal sepsis in women with preterm prelabour rupture of membranes. PLoS One. (2013) 8:e69341. 10.1371/journal.pone.0069341
    1. Labenne M, Lizard G, Ferdynus C, Montange T, Iacobelli S, Bonsante F, et al. A clinic-biological score for diagnosing early-onset neonatal infection in critically ill preterm infants. Pediatr Crit Care Med. (2011) 12:203–9. 10.1097/PCC.0b013e3181e2a53b
    1. Smulian JC, Bhandari V, Campbell WA, Rodis JF, Vintzileos AM. Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis. J Mater Fetal Med. (1997) 6:254–9. 10.1002/(SICI)1520-6661(199709/10)6:5<254::AID-MFM2>;2-F
    1. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr. (1999) 88:647–50. 10.1080/08035259950169314
    1. Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr. (1996) 129:574–80. 10.1016/s0022-3476(96)70123-3
    1. Gilfillan M, Bhandari V. Biomarkers for the diagnosis of neonatal sepsis and necrotizing enterocolitis: clinical practice guidelines. Early Hum Dev. (2017) 105:25–33. 10.1016/j.earlhumdev.2016.12.002
    1. Küster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet. (1998) 352:1271–7. 10.1016/S0140-6736(98)08148-3
    1. Schibler KR, Liechty KW, White WL, Rothstein G, Christensen RD. Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr Res. (1992) 31:18–21. 10.1203/00006450-199201000-00003
    1. Santana C, Guindeo MC, González G, García-Muñoz F, Saavedra P, Doménech E. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr. (2001) 90:1176–81. 10.1080/080352501317061602
    1. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Edn. (2004) 89:F229–35.
    1. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Edn. (1997) 77:F221–7. 10.1136/fn.77.3.f221
    1. Steinberger E, Hofer N, Resch B. Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants. Scand J Clin Lab Invest. (2014) 74:432–6. 10.3109/00365513.2014.900696
    1. Chiesa C, Signore F, Assumma M, Buffone E, Tramontozzi P, Osborn JF, et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem. (2001) 47:1016–22.
    1. He Y, Du WX, Jiang HY, Ai Q, Feng J, Liu Z, et al. Multiplex cytokine profiling identifies interleukin-27 as a novel biomarker for neonatal early onset sepsis. Shock. (2017) 47:140–7. 10.1097/SHK.0000000000000753
    1. Cernada M, Badía N, Modesto V, Alonso R, Mejías A, Golombek S, et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr. (2012) 101:e203–7. 10.1111/j.1651-2227.2011.02577.x
    1. Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J. (2000) 19:879–87. 10.1097/00006454-200009000-00014
    1. Chiesa C, Pacifico L, Natale F, Hofer N, Osborn JF, Resch B. Fetal and early neonatal interleukin-6 response. Cytokine. (2015) 76:1–12. 10.1016/j.cyto.2015.03.015
    1. Newcombe RGAD. Proportions and Their Differences. Statistics With Confidence. 2nd ed. London: BMJ Books; (2005). p. 45–56.
    1. Delanghe JR, Speeckaert MM. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta (2015) 451(Pt A):46–64. 10.1016/j.cca.2015.01.031
    1. Qiu X, Zhang L, Tong Y, Qu Y, Wang H, Mu D. Interleukin-6 for early diagnosis of neonatal sepsis with premature rupture of the membranes: a meta-analysis. Medicine. (2018) 97:e13146. 10.1097/MD.0000000000013146
    1. Fan Y, Yu JL. Umbilical blood biomarkers for predicting early-onset neonatal sepsis. World J Pediatr. (2012) 8:101–8. 10.1007/s12519-012-0347-3
    1. Su H, Chang SS, Han CM, Wu KY, Li MC, Huang CY, et al. Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis. J Perinatol. (2014) 34:268–74. 10.1038/jp.2013.186
    1. Hofer N, Kothari R, Morris N, Müller W, Resch B. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol. (2013) 209:542.e1–11. 10.1016/j.ajog.2013.08.030
    1. Gharehbaghi MM, Peirovifar A, Gharehbaghi PM. Comparison of umbilical cord interleukin-6 in preterm infants with premature rupture of membranes and intact membranes. Saudi Med J. (2008) 29:224–8.
    1. Smulian JC, Vintzileos AM, Lai YL, Santiago J, Shen-Schwarz S, Campbell WA. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J Mater Fetal Med. (1999) 8:88–94. 10.1002/(SICI)1520-6661(199905/06)8:3<88::AID-MFM4>;2-#
    1. Ahmed AM, Mohammed AT, Bastawy S, Attalla HA, Yousef AA, Abdelrazek MS, et al. Serum biomarkers for the early detection of the early-onset neonatal sepsis: a single-center prospective study. Adv Neonatal Care. (2019) 19:E26–32. 10.1097/ANC.0000000000000631
    1. Bender L, Thaarup J, Varming K, Krarup H, Ellermann-Eriksen S, Ebbesen F. Early and late markers for the detection of early-onset neonatal sepsis. Danish Med Bull. (2008) 55:219–23.
    1. Panero A, Pacifico L, Rossi N, Mancuso G, Stegagno M, Chiesa C. Interleukin 6 in neonates with early and late onset infection. Pediatr Infect Dis J. (1997) 16:370–5.
    1. Krueger M, Nauck MS, Sang S, Hentschel R, Wieland H, Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate. (2001) 80:118–23. 10.1159/000047130
    1. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem. (2003) 49:60–8. 10.1373/49.1.60
    1. Martin H, Olander B, Norman M. Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics. (2001) 108:E61. 10.1542/peds.108.4.e61
    1. Lehrnbecher T, Schrod L, Rutsch P, Roos T, Martius J, von Stockhausen HB. Immunologic parameters in cord blood indicating early-onset sepsis. Biol Neonate. (1996) 70:206–12. 10.1159/000244366
    1. Al-Zahrani A, Ghonaim MM, Hussein YM, Eed EM, Khalifa AS, Dorgham LS. Evaluation of recent methods versus conventional methods for diagnosis of early-onset neonatal sepsis. J Infect Dev Ctries. (2015) 9:388–93. 10.3855/jidc.5950
    1. Berner R, Fürll B, Stelter F, Dröse J, Müller HP, Schütt C. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol. (2002) 9:440–5. 10.1128/cdli.9.2.440-445.2002
    1. Canpolat FE, Yiðit S, Korkmaz A, Yurdakök M, Tekinalp G. Procalcitonin versus CRP as an early indicator of fetal infection in preterm premature rupture of membranes. Turk J Pediatr. (2011) 53:180–6.
    1. Cetin O, Dokurel Cetin I, Uludag S, Sen C, Verit FF, Guralp O. Serial ultrasonographic examination of the fetal thymus in the prediction of early neonatal sepsis in preterm premature rupture of membranes. Gynecol Obstet Invest. (2014) 78:201–7. 10.1159/000364871
    1. Rego MA, Martinez FE, Elias J, Mussi-Pinhata MM. Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress. J Perinat Med. (2010) 38:527–33. 10.1515/jpm.2010.071
    1. Hatzidaki E, Gourgiotis D, Manoura A, Korakaki E, Bossios A, Galanakis E, et al. Interleukin-6 in preterm premature rupture of membranes as an indicator of neonatal outcome. Acta Obstet Gynecol Scand. (2005) 84:632–8. 10.1111/j.0001-6349.2005.00747.x
    1. Døllner H, Vatten L, Linnebo I, Zanussi GF, Laerdal A, Austgulen R. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate. (2001) 80:41–7. 10.1159/000047118
    1. Resch B, Gusenleitner W, Müller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr. (2003) 92:243–5. 10.1111/j.1651-2227.2003.tb00534.x
    1. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res. (1998) 44:469–77. 10.1203/00006450-199810000-00002
    1. Sun B, Liang LF, Li J, Yang D, Zhao XB, Zhang KG. A meta-analysis of interleukin-6 as a valid and accurate index in diagnosing early neonatal sepsis. Int Wound J. (2019) 16:527–33. 10.1111/iwj.13079
    1. de Groot JA, Dendukuri N, Janssen KJ, Reitsma JB, Bossuyt PM, Moons KG. Adjusting for differential-verification bias in diagnostic-accuracy studies: a Bayesian approach. Epidemiology. (2011) 22:234–41. 10.1097/EDE.0b013e318207fc5c
    1. Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ. (2006) 174:469–76. 10.1503/cmaj.050090
    1. Sarafidis K, Soubasi-Griva V, Piretzi K, Thomaidou A, Agakidou E, Taparkou A, et al. Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates. Intensive Care Med. (2010) 36:864–8. 10.1007/s00134-010-1819-3
    1. Arnon S, Litmanovitz I, Regev R, Bauer S, Lis M, Shainkin-Kestenbaum R, et al. Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants. Biol Neonate. (2005) 87:105–10. 10.1159/000081979
    1. Jung E, Romero R, Yeo L, Diaz-Primera R, Marin-Concha J, Para R, et al. The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications. Semin Fetal Neonatal Med. (2020) 25:101146. 10.1016/j.siny.2020.101146
    1. Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics. (1993) 91:617–23.
    1. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. (1978) 299:926–30. 10.1056/NEJM197810262991705
    1. Worster A, Carpenter C. Incorporation bias in studies of diagnostic tests: how to avoid being biased about bias. CJEM. (2008) 10:174–5. 10.1017/s1481803500009891

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi